5AM Ventures Closes $200M Life Sciences Fund
Menlo Park-based 5AM Venture Management said Monday that it has raised $200M in 5AM Ventures III, L.P., the firm's venture capital fund focused on early-stage life sciences companies. The firm said the funding came from both current and new institutional investors, including endowments, family offices, foundations, funds-of-funds and pension funds. Specific LPs in the new fund were not disclosed. The fund said it will continue to focus on early-stage life science, and specifically companies focused on the discovery and development of novel therapeutics, along with companies developing diagnostics, materials, medical devices and reagents.
posted on Monday, December 7, 2009
Related companies:
5AM Ventures
Related stories:
> Montreux Closes $250M Life Sciences Fund
> Skyline Ventures Closes $350M Fund
> Vivo Ventures Closes $275M Life Science Venture Fund
> Crosslink Capital Closes $200M Fund
> Emergence Capital Partners Closes $200M Fund
silicontap.com Home